In vitro studies regarding the feasibility of bovine erythrocyte xenotransfusion

Xenotransplantation

Volumn 11, Issue 1, 2004, Pages 11-17

  Johnstone, James E ^a   MacLaren, Leslie A ^a   Doucet, Jay ^a   McAlister, Vivian C ^a,b,c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Blood group; Blood transfusion; Cow; Flow cytometry; Hemagglutination, heterologous; Incompatibility; Osmotic fragility; Swine; Transplantation

Indexed keywords

ANTIGEN; HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BLOOD DONOR; BLOOD GROUP O; BLOOD TRANSFUSION; CELL TRANSPLANTATION; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; COW; ERYTHROCYTE TRANSFUSION; ERYTHROCYTE XENOTRANSFUSION; FLOW CYTOMETRY; HEMAGGLUTINATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; OSMOTIC FRAGILITY; PHLEBOTOMY; PRIORITY JOURNAL; SPECIES DIFFERENCE; SWINE; VASCULAR ACCESS; XENOTRANSPLANTATION;

ABO BLOOD-GROUP SYSTEM; ANIMALS; ANTIGENS, HETEROPHILE; CATTLE; COMPLEMENT HEMOLYTIC ACTIVITY ASSAY; COMPLEMENT SYSTEM PROTEINS; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEASIBILITY STUDIES; FEMALE; HEMAGGLUTINATION TESTS; HUMANS; SWINE;

EID: 0742271160     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2004.00070.x     Document Type: Article

References (33)

1. VAN HULST M, DE WOLF JT, STAGINNUS U, RUITENBERG EJ, POSTMA MJ. Pharmaco-economics of blood transfusion safety: review of the available evidence. Vox Sang 2002; 83: 146.
2. STEPHENSON J. Investigation probes risk of contracting West Nile virus via blood transfusions. J Am Med Assoc 2002; 288: 1573.
3. MORTIMER JJ. Making blood safer. BMJ 2002; 325: 400.
4. WALLACE EL, CHURCHILL WH, SURGENOR DM, CHO GS, MCGURK S. Collection and transfusion of blood and blood components in the United States, 1994. Transfusion 1998; 38: 625.
5. PARADIS K, LANGFORD G, LONG Z et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 1999; 20: 1236.
6. BLUSCH JH, PATIENCE C, MARTIN U. Pig endogenous retroviruses and xenotransplantation. Xenotransplantation 2002; 9: 242.
7. HAY CR, LOZIER JN, LEE CA et al. Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors: the results of an international survey. Thromb Haemost 1996; 75: 25.
8. WELLS GAH, MCGILL IS. Recently described scrapie-like encephaolopathies of animals: case definitions. Res Vet Sci 1992; 53: 1.
9. MIELE G, MANSON J, CLINTON M. A novel erythroid-specific marker of transmissible spongiform encephalopathies. Nat Med 2001; 7: 361.
10. CRONKITE EP, LOZNER EL, DEAVER JM. Use of thrombin and fibrinogen in skin grafting. JAMA 1944; 124: 976.
11. VANBERKEL PH, WELLING MM, GEERTS M et al. Large scale production of recombinant human lactoferrin in the milk of transgenic cows. Nat Biotechnol 2002; 20: 84.
12. WERLE E, TRAUTSCHOLD I, HAENDLE H, FRITZ H. Physiologic, pharmacologic, and clinical aspects of proteinase inhibitors. Ann N Y Acad Sci 1968; 146: 464.
13. SQUIRES JE. Artificial blood. Science 2002; 295: 1002.
14. BROWN H. Jean Denis and transfusion of blood, Paris 1667-1668. ISIS 1948; 39: 15.
15. MACLAREN LA, LEE TD, ANDERSON D, NASS M, MCALISTER VC. Variation in porcine red blood cell alpha-galactosyl expression and agglutination by human serum. Transplant Proc 1998; 5: 2468.
16. MACLAREN LA, RIGGS CM, JOHNSTONE J, DOUCET J, MCALISTER VC. Evaluating porcine red blood cell and platelet cx-galactosyl expression. Transfusion 2002; 42: 1184.
17. GALILI U, SHOHET SB, KOBRIN E, STULTS CL, MACHER BA. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem 1988; 263: 17755.
18. GALILI U, LATEMPLE DC, WALGENBACH AW, STONE KR. Porcine and bovine cartilage transplants in cynomologous monkey: II. Changes in anti-gal response during chronic rejection. Transplantation 1997; 63: 646.
19. ALVARADO CG, COTTERELL AH, MCCURRY KR. Variation in the level of xenoantigen expression in porcine organs. Transplantation 1995; 59: 1589.
20. HAMAZAKI H, HOTTA K, KONISHI K. Comparative studies of human, equine, porcine and bovine erythrocyte membrane sialoglycoproteins. Comp Biochem Physiol 1976; 55: 37.
21. STORMONT CJ. Blood groups in animals. J Am Vet Med Assoc 1982; 181: 1120.
22. USHA AP. Blood groups and diversity by blood typing in cattle. PhD Thesis, Scotland, UK: University of Edinburgh, 1996.
23. HARMENING DH. Modern blood banking and Transfusion Practices, 4th edn. Philadelphia, PA: F.A. Davis Company, 1999.
24. NEIMANN-SORENSEN A, RENDAL J, STONE WH. The J-substance of cattle. II. A comparison of normal antibodies and antigens in sheep, cattle and man. J Immunol 1954; 73: 407.
25. THIELE OW, KOCH J. Haptenic relationship between bovine J, human A and porcine A blood group systems tested with lipids and lipid fractions of blood. Vox Sang 1973; 25: 317.
26. GOLD ER. Reactions of anti-J, anti-R and pig anti-A with human group A cells. Vox Sang 1967; 13: 181.
27. ECKERMAN JM, BUHLER L, AWWAD M, ZHU A, COOPER DKC. Alpha-galactosidase-treated pig red blood cell transfusion in primates - initial studies. Transplantation 2002; 74 (Suppl. 4): 630.
28. ZHU A. Binding of human natural antibodies to non-alphaGal xenoantigens on porcine erythrocytes. Transplantation 2000; 69: 2422.
29. DOUCET J, GAO ZH, MACLAREN L, JOHNSTONE J, McALISTER VC. Modification of porcine erythrocyte xenoantigens. S556. Transplantation 1999; 67: S556.
30. HAYASHI S, ISOBE K, EMI N et al. Inhibition of human complement-dependent cell lysis by bovine aortic endothelial cells transfected with membrane-bound complement-regulatory factor (DAF and HRF20) gene using a retroviral vector. Eur Surg Res 1996; 28: 440.
31. COHN SM. Blood substitutes in surgery. Surgery 2000; 127: 599.
32. LIGLER FS, STRATTON LP, RUDOLPH AS. Liposome encapsulated hemoglobin: stabilization, encapsulation, and storage. Prog Clin Biol Res 1989; 319: 435.
33. PIRO S, LUPI R, DOTTA F et al. Bovine islets are less susceptible than human islets to damage by human cytokines. Transplantation 2001; 71: 21.